Vaxelis Global Market Report 2025

Vaxelis Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Pertussis, Diphtheria, Tetanus), By Distribution Channel (Hospitals, Retail Pharmacies, Government Supplies), By End Use (Hospitals, Clinics, Ambulatory Care, Home Care)

Name: Vaxelis Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Vaxelis Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

What Is Covered Under Vaxelis Market?

Vaxelis is a six-in-one vaccine that helps prevent diphtheria, tetanus, whooping cough, polio, haemophilus influenzae type B infections, and hepatitis B. It is primarily used in infants and children as part of standard vaccination programs.

The main indications on the vaxelis include Pertussis, diphtheria, and tetanus. Pertussis is a highly contagious respiratory infection caused by bordetella pertussis, characterized by severe coughing fits that can lead to difficulty breathing. Vaxelis provides protection against pertussis by stimulating the immune system to prevent infection and reduce the severity of symptoms in children. It is distributed through various channels such as hospitals, retail pharmacies, and government supplies and used by several end users such as hospitals, clinics, ambulatory care, and home care.

What Is The Vaxelis Market Size 2025 And Growth Rate?

The vaxelis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to an increase in government funding for immunization programs, a rise in awareness of vaccine-preventable diseases, an increase in the pediatric population, an increase in public health investments, and an increase in funding for vaccine research and development.

What Is The Vaxelis Market Growth Forecast?

The vaxelis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising incidences of vaccine-preventable diseases, rising prevalence of infectious diseases, rising consumer trust in vaccination, rising demand for cost-effective vaccines, rising birth rates in developing regions, and increasing immunization coverage initiatives. Major trends in the forecast period include advancements in combination vaccine technology, advancements in vaccine production, advancements in cold chain infrastructure, innovation in vaccine formulation, and integration of digital health platforms.

Vaxelis Market Size and growth rate 2025 to 2029: Graph

How Is The Vaxelis Market Segmented?

The vaxelis market covered in this report is segmented –

1) By Indication: Pertussis; Diphtheria; Tetanus

2) By Distribution Channel: Hospitals; Retail Pharmacies; Government Supplies

3) By End Use: Hospitals; Clinics; Ambulatory Care; Home Care

Book your 30 minutes free consultation with our research experts

What Is Driving The Vaxelis Market? Impact Of Growing Pediatric Population On Vaccine Demand

The rise in pediatric population is expected to drive the growth of the vaxelis market going forward. The rising pediatric population is driven by improved healthcare, nutrition, maternal care, reduced infant mortality, and increased awareness of child health and vaccination efforts. Vaxelis protects children against six serious diseases in one convenient vaccine, reducing the burden of multiple immunizations. For instance, in December 2024, according to the Child Stats, a US-based federal interagency forum for child and family statistics, in 2022, the United States had 72.5 million children, and the number is projected to increase to 78.2 million by 2050. Therefore, the rise in pediatric population is driving the growth of vaxelis market.

What Is Driving The Vaxelis Market? Impact Of Rising Hepatitis B Prevalence On Vaccine Demand

The increase in the prevalence of hepatitis B cases is expected to propel the growth of the vaxelis market going forward. Hepatitis B refers to a viral infection caused by the hepatitis B virus (HBV) that affects the liver, potentially leading to both acute and chronic diseases such as liver cirrhosis and liver cancer. The growing number of hepatitis B cases is due to factors like insufficient vaccination, weak healthcare systems, high-risk activities such as needle sharing, and limited public awareness about prevention. Vaxelis helps patients by providing immunity against hepatitis B through the inclusion of the hepatitis B surface antigen in its formulation, preventing infection and its associated complications. For instance, in April 2024, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported that an estimated 257 million people worldwide (3.2%) were living with HBV infection in 2022, with approximately 1.5 million new cases occurring annually. Therefore, the increase in the prevalence of hepatitis B cases is driving the growth of the vaxelis market.

What Is Driving The Vaxelis Market? Impact Of Rising Healthcare Expenditure On Vaccine Access And Adoption

Rise in healthcare expenditure is expected to propel the growth of the vaxelis market going forward. Healthcare expenditure is attributed to the financial investment made by governments, private insurers, and individuals in the healthcare system to improve and expand medical services. Healthcare expenditure helps vaxelis by supporting vaccination programs, improving access to immunization, and funding public health initiatives that increase awareness and distribution of vaccines, thereby driving demand and adoption. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in the UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Thus, the rise in healthcare expenditure is driving the growth of the vaxelis market.

Who Are The Major Players In The Global Vaxelis Market?

Major companies operating in the vaxelis market are Merck & Co. Inc.; Sanofi S.A.

Regional Analysis For The Global Vaxelis Market

North America was the largest region in the vaxelis market in 2024. The regions covered in the vaxelis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vaxelis market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Vaxelis Market?

The vaxelis market consists of sales of active ingredients and antigens, vaccine administration supplies, and cold chain equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Vaxelis Industry?

The vaxelis market research report is one of a series of new reports from The Business Research Company that provides vaxelis market statistics, including the vaxelis industry's global market size, regional shares, competitors with a vaxelis market share, detailed vaxelis market segments, market trends and opportunities, and any further data you may need to thrive in the vaxelis industry. This vaxelis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Vaxelis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The vaxelis market covered in this report is segmented – 1) By Indication: Pertussis; Diphtheria; Tetanus 2) By Distribution Channel: Hospitals; Retail Pharmacies; Government Supplies 3) By End Use: Hospitals; Clinics; Ambulatory Care; Home Care
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co. Inc.; Sanofi S.A.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Vaxelis Market Characteristics

3. Vaxelis Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Vaxelis Market Trends And Strategies

5. Vaxelis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Vaxelis Growth Analysis And Strategic Analysis Framework

6.1. Global Vaxelis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Vaxelis Market Growth Rate Analysis

6.4. Global Vaxelis Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Vaxelis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Vaxelis Total Addressable Market (TAM)

7. Global Vaxelis Pricing Analysis & Forecasts

8. Vaxelis Market Segmentation

8.1. Global Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pertussis

Diphtheria

Tetanus

8.2. Global Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Retail Pharmacies

Government Supplies

8.3. Global Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Clinics

Ambulatory Care

Home Care

9. Global Vaxelis Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Vaxelis Market Regional And Country Analysis

10.1. Global Vaxelis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Vaxelis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Vaxelis Market

11.1. Asia-Pacific Vaxelis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Vaxelis Market

12.1. China Vaxelis Market Overview

12.2. China Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Vaxelis Market

13.1. India Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Vaxelis Market

14.1. Japan Vaxelis Market Overview

14.2. Japan Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Vaxelis Market

15.1. Australia Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Vaxelis Market

16.1. South Korea Vaxelis Market Overview

16.2. South Korea Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Vaxelis Market

17.1. Western Europe Vaxelis Market Overview

17.2. Western Europe Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Vaxelis Market

18.1. UK Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Vaxelis Market

19.1. Germany Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Vaxelis Market

20.1. France Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Vaxelis Market

21.1. Eastern Europe Vaxelis Market Overview

21.2. Eastern Europe Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Vaxelis Market

22.1. North America Vaxelis Market Overview

22.2. North America Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Vaxelis Market

23.1. USA Vaxelis Market Overview

23.2. USA Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Vaxelis Market

24.1. Canada Vaxelis Market Overview

24.2. Canada Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Vaxelis Market

25.1. South America Vaxelis Market Overview

25.2. South America Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Vaxelis Market

26.1. Middle East Vaxelis Market Overview

26.2. Middle East Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Vaxelis Market

27.1. Africa Vaxelis Market Overview

27.2. Africa Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Vaxelis Market Competitive Landscape And Company Profiles

28.1. Vaxelis Market Competitive Landscape

28.2. Vaxelis Market Company Profiles

28.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

28.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

29. Global Vaxelis Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Vaxelis Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Vaxelis Market

32. Recent Developments In The Vaxelis Market

33. Vaxelis Market High Potential Countries, Segments and Strategies

33.1 Vaxelis Market In 2029 - Countries Offering Most New Opportunities

33.2 Vaxelis Market In 2029 - Segments Offering Most New Opportunities

33.3 Vaxelis Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Vaxelis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Vaxelis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Merck & Co. Inc. Financial Performance

Table 60: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Vaxelis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Vaxelis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Vaxelis Market, Segmentation By indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Vaxelis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Vaxelis Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Merck & Co. Inc. Financial Performance

Figure 60: Sanofi S.A. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Influenza Diagnostics Market 2022 – By Traditional Diagnostic Tests (Rapid Influenza Diagnostics Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests), By Molecular Diagnostic Tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End-User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2031

View Report

Influenza Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diphtheria Global Market Report 2025 – By Type (Diphtheria, Skin Diphtheria, Other Types), By Diagnosis (Physical Examination, Throat Culture, Other Diagnosis), By Treatment (Antibiotics, Antitoxin, Other Treatments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cough And Cold Preparations Global Market Report 2025 – By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Drug Types), By Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Other Dosage Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Chronic Cough Global Market Report 2025 – By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes), By Route Of Administration (Oral, Inhalational, Injectable, Other Route of Administrations), By End-Users (Hospitals, Homecare, Specialty Centers, Other End Users), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cough Hypersensitivity Syndrome Global Market Report 2025 – By Drug Class (Inhales Corticosteroids, Antitussive Agents, Short-acting Beta-2 Agonists, Anticholinergics, Proton Pump Inhibitors, Antihistamines, Other Drugs), By Route of Administration (Oral, Inhalation, Other Route Of Administration), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Influenza Diagnostic Global Market Report 2025 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnostic tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cough And Cold Preparations Market 2023 – By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Drug Types), By Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Other Dosage Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Other Distribution Channels), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Frequently Asked Questions

What is the definition of the Vaxelis market?

How will the Vaxelis market drivers and restraints affect the market dynamics? What forces will shape the Vaxelis industry going forward?

The Vaxelis market major growth driver - Impact Of Growing Pediatric Population On Vaccine Demand. For further insights on the Vaxelis market, request a sample here

What is the forecast market size or the forecast market value of the Vaxelis market?

The Vaxelis market size has grown strongly in recent years. The vaxelis market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to an increase in government funding for immunization programs, a rise in awareness of vaccine-preventable diseases, an increase in the pediatric population, an increase in public health investments, and an increase in funding for vaccine research and development. The vaxelis market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising incidences of vaccine-preventable diseases, rising prevalence of infectious diseases, rising consumer trust in vaccination, rising demand for cost-effective vaccines, rising birth rates in developing regions, and increasing immunization coverage initiatives. Major trends in the forecast period include advancements in combination vaccine technology, advancements in vaccine production, advancements in cold chain infrastructure, innovation in vaccine formulation, and integration of digital health platforms. For further insights on the Vaxelis market, request a sample here

How is the Vaxelis market segmented?

The vaxelis market covered in this report is segmented –
1) By Indication: Pertussis; Diphtheria; Tetanus
2) By Distribution Channel: Hospitals; Retail Pharmacies; Government Supplies
3) By End Use: Hospitals; Clinics; Ambulatory Care; Home Care For further insights on the Vaxelis market, request a sample here

Which region has the largest share of the Vaxelis market? What are the other regions covered in the report?

Who are the major players in the Vaxelis market?

Major companies operating in the vaxelis market are Merck & Co. Inc.; Sanofi S.A. . For further insights on the Vaxelis market, request a sample here.

What are the key trends in the Vaxelis market?

Major trends in the Vaxelis market include . For further insights on the Vaxelis market, request a sample here.

What are the major opportunities in the Vaxelis market? What are the strategies for the Vaxelis market?

For detailed insights on the major opportunities and strategies in the Vaxelis market, request a sample here.

How does the Vaxelis market relate to the overall economy and other similar markets?

For detailed insights on Vaxelis's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Vaxelis industry?

For detailed insights on the mergers and acquisitions in the Vaxelis industry, request a sample here.

What are the key dynamics influencing the Vaxelis market growth? SWOT analysis of the Vaxelis market.

For detailed insights on the key dynamics influencing the Vaxelis market growth and SWOT analysis of the Vaxelis industry, request a sample here.

Vaxelis Global Market Report 2025

Vaxelis Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Pertussis, Diphtheria, Tetanus), By Distribution Channel (Hospitals, Retail Pharmacies, Government Supplies), By End Use (Hospitals, Clinics, Ambulatory Care, Home Care)

Vaxelis Global Market Report 2025

What Is Covered Under Vaxelis Market?

What Is The Vaxelis Market Size 2025 And Growth Rate?

What Is The Vaxelis Market Growth Forecast?

How Is The Vaxelis Market Segmented?

What Is Driving The Vaxelis Market? Impact Of Growing Pediatric Population On Vaccine Demand

What Is Driving The Vaxelis Market? Impact Of Rising Hepatitis B Prevalence On Vaccine Demand

What Is Driving The Vaxelis Market? Impact Of Rising Healthcare Expenditure On Vaccine Access And Adoption

Who Are The Major Players In The Global Vaxelis Market?

Regional Analysis For The Global Vaxelis Market

What Defines the Vaxelis Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Vaxelis Industry?

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions